What is the share price of Ambuja Cements Ltd (AMBUJACEM) today?
The share price of AMBUJACEM as on 3rd February 2026 is ₹528.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ambuja Cements Ltd (AMBUJACEM) share?
The past returns of Ambuja Cements Ltd (AMBUJACEM) share are- Past 1 week: 0.30%
- Past 1 month: -7.41%
- Past 3 months: -8.48%
- Past 6 months: -12.72%
- Past 1 year: 6.68%
- Past 3 years: 41.39%
- Past 5 years: 96.41%
What are the peers or stocks similar to Ambuja Cements Ltd (AMBUJACEM)?
The peers or stocks similar to Ambuja Cements Ltd (AMBUJACEM) include:What is the dividend yield % of Ambuja Cements Ltd (AMBUJACEM) share?
The current dividend yield of Ambuja Cements Ltd (AMBUJACEM) is 0.38.What is the market cap of Ambuja Cements Ltd (AMBUJACEM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ambuja Cements Ltd (AMBUJACEM) is ₹130574.08 Cr as of 3rd February 2026.What is the 52 week high and low of Ambuja Cements Ltd (AMBUJACEM) share?
The 52-week high of Ambuja Cements Ltd (AMBUJACEM) is ₹624.95 and the 52-week low is ₹455.What is the PE and PB ratio of Ambuja Cements Ltd (AMBUJACEM) stock?
The P/E (price-to-earnings) ratio of Ambuja Cements Ltd (AMBUJACEM) is 31.33. The P/B (price-to-book) ratio is 2.05.Which sector does Ambuja Cements Ltd (AMBUJACEM) belong to?
Ambuja Cements Ltd (AMBUJACEM) belongs to the Materials sector & Cement sub-sector.How to buy Ambuja Cements Ltd (AMBUJACEM) shares?
You can directly buy Ambuja Cements Ltd (AMBUJACEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ambuja Cements Ltd
AMBUJACEM Share Price
AMBUJACEM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AMBUJACEM Performance & Key Metrics
AMBUJACEM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.72 | 2.05 | 0.38% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 29.50 | 3.38 | 1.50% |
from 42 analysts
Price Upside
Earnings Growth
Rev. Growth
AMBUJACEM Company Profile
Ambuja Cements Limited is a cement manufacturing company. The Company manufactures Portland Pozollana cement (PPC).
AMBUJACEM Sentiment Analysis
AMBUJACEM Sentiment Analysis
AMBUJACEM Stock Summary · August 2025
Ambuja Cements has demonstrated remarkable financial strength, achieving record quarterly revenue of Rs. 10,289 crores, driven by a robust sales volume and a strategic focus on premium products. The company’s commitment to operational efficiency is evident in its record EBITDA of Rs. 1,961 crores and a strong profit after tax of Rs. 970 crores, despite facing challenges from rising operational costs and the integration of newly acquired assets. With a debt-free status and a solid cash balance of ₹3,000 crores, Ambuja is well-positioned for future growth, particularly as cement demand is projected to rise due to government initiatives. The emphasis on sustainability and community engagement further enhances its market positioning, while ongoing investments in brand promotion are expected to bolster pricing power and overall profitability.
AMBUJACEM Stock Growth Drivers
AMBUJACEM Stock Growth Drivers
6Record Financial Performance
In the first quarter of FY26, the company achieved its highest ever sales volume of
Operational Efficiency and Cost Management
The company has implemented significant cost improvements, achieving a reduction of ₹119 per metric tonne
AMBUJACEM Stock Challenges
AMBUJACEM Stock Challenges
5Declining Cash Position
The company's cash position has significantly decreased, with approximately ₹3,000 crores reported at the end
Volume Discrepancies and Growth Concerns
There is a noted discrepancy in consolidated volume figures, with the current quarter's volume reported
AMBUJACEM Forecast
AMBUJACEM Forecasts
Price
Revenue
Earnings
AMBUJACEM Share Price Forecast
AMBUJACEM Share Price Forecast
All values in ₹
All values in ₹
AMBUJACEM Company Revenue Forecast
AMBUJACEM Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
AMBUJACEM Stock EPS (Earnings Per Share) Forecast
AMBUJACEM Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
AMBUJACEM
AMBUJACEM
Income
Balance Sheet
Cash Flow
AMBUJACEM Income Statement
AMBUJACEM Income Statement
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 23,944.07 | 26,424.91 | 27,704.26 | 24,980.20 | 29,338.13 | 31,448.03 | 44,822.92 | 38,702.55 | 42,807.08 | 41,087.54 | ||||||||||
| Raw Materials | 19,751.11 | 22,181.93 | 22,506.56 | 19,686.61 | 22,875.51 | 27,259.62 | 5,230.77 | 5,478.10 | 6,471.73 | 33,016.21 | ||||||||||
| Power & Fuel Cost | 11,761.90 | 8,085.54 | 8,347.84 | |||||||||||||||||
| Employee Cost | 1,856.53 | 1,352.79 | 1,403.41 | |||||||||||||||||
| Selling & Administrative Expenses | 16,320.85 | 13,060.40 | 14,194.15 | |||||||||||||||||
| Operating & Other expenses | 4,083.81 | 2,925.34 | 3,773.30 | |||||||||||||||||
| EBITDA | 4,192.96 | 4,242.98 | 5,197.70 | 5,293.59 | 6,462.62 | 4,188.41 | 5,569.06 | 7,800.38 | 8,616.65 | 8,071.33 | ||||||||||
| Depreciation/Amortization | 1,219.45 | 1,153.94 | 1,152.52 | 1,161.78 | 1,152.49 | 1,292.34 | 1,644.67 | 1,627.90 | 2,478.34 | 3,428.89 | ||||||||||
| PBIT | 2,973.51 | 3,089.04 | 4,045.18 | 4,131.81 | 5,310.13 | 2,896.07 | 3,924.39 | 6,172.48 | 6,138.31 | 4,642.44 | ||||||||||
| Interest & Other Items | 205.78 | 170.50 | 169.87 | 140.22 | 145.66 | 155.47 | 194.90 | 276.38 | 215.94 | 217.10 | ||||||||||
| PBT | 2,767.73 | 2,918.54 | 3,875.31 | 3,991.59 | 5,164.47 | 2,740.60 | 3,729.49 | 5,896.10 | 5,922.37 | 4,425.34 | ||||||||||
| Taxes & Other Items | 1,251.37 | 741.14 | 1,780.31 | 1,626.15 | 2,384.09 | 802.14 | 1,146.09 | 2,322.70 | 1,754.94 | 664.47 | ||||||||||
| Net Income | 1,516.36 | 2,177.40 | 2,095.00 | 2,365.44 | 2,780.38 | 1,938.46 | 2,583.40 | 3,573.40 | 4,167.43 | 3,760.87 | ||||||||||
| EPS | 7.64 | 10.97 | 10.55 | 11.91 | 14.00 | 9.76 | 13.01 | 17.08 | 17.88 | 15.27 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 | 2.00 | 2.00 | 2.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.12 | 0.11 | 0.13 |
AMBUJACEM Company Updates
Investor Presentation
AMBUJACEM Stock Peers
AMBUJACEM Past Performance & Peer Comparison
AMBUJACEM Past Performance & Peer Comparison
MaterialsCement
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ambuja Cements Ltd | 31.33 | 2.05 | 0.38% |
| UltraTech Cement Ltd | 61.32 | 5.01 | 0.62% |
| Grasim Industries Ltd | 51.43 | 1.21 | 0.36% |
| Shree Cement Ltd | 86.83 | 4.52 | 0.41% |
AMBUJACEM Stock Price Comparison
Compare AMBUJACEM with any stock or ETFAMBUJACEM Holdings
AMBUJACEM Shareholdings
AMBUJACEM Promoter Holdings Trend
AMBUJACEM Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
AMBUJACEM Institutional Holdings Trend
AMBUJACEM Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMBUJACEM Shareholding Pattern
AMBUJACEM Shareholding Pattern
AMBUJACEM Shareholding History
AMBUJACEM Shareholding History
Mutual Funds Invested in AMBUJACEM
Mutual Funds Invested in AMBUJACEM
No mutual funds holding trends are available
Top 5 Mutual Funds holding Ambuja Cements Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9829% | Percentage of the fund’s portfolio invested in the stock 3.05% | Change in the portfolio weight of the stock over the last 3 months -0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/57 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5030% | Percentage of the fund’s portfolio invested in the stock 1.52% | Change in the portfolio weight of the stock over the last 3 months -0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/94 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3626% | Percentage of the fund’s portfolio invested in the stock 0.42% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 31/324 (0) |
Compare 3-month MF holding change on Screener
smallcases containing AMBUJACEM stock
smallcases containing AMBUJACEM stock
Looks like this stock is not in any smallcase yet.
AMBUJACEM Events
AMBUJACEM Events
AMBUJACEM Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
AMBUJACEM Dividend Trend
No dividend trend available
AMBUJACEM Upcoming Dividends
AMBUJACEM Upcoming Dividends
No upcoming dividends are available
AMBUJACEM Past Dividends
AMBUJACEM Past Dividends
Cash Dividend
Ex DateEx DateJun 13, 2025
Dividend/Share
₹2.00
Ex DateEx Date
Jun 13, 2025
Cash Dividend
Ex DateEx DateJun 14, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Jun 14, 2024
Cash Dividend
Ex DateEx DateJul 7, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Jul 7, 2023
Cash Dividend
Ex DateEx DateMar 30, 2022
Dividend/Share
₹6.30
Ex DateEx Date
Mar 30, 2022
Cash Dividend
Ex DateEx DateMar 19, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Mar 19, 2021
AMBUJACEM Stock News & Opinions
AMBUJACEM Stock News & Opinions
Net profit of Ambuja Cements declined 90.56% to Rs 203.70 crore in the quarter ended December 2025 as against Rs 2158.21 crore during the previous quarter ended December 2024. Sales rose 9.19% to Rs 10276.65 crore in the quarter ended December 2025 as against Rs 9411.35 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales10276.659411.35 9 OPM %13.1718.19 - PBDT1386.673000.05 -54 PBT427.642393.37 -82 NP203.702158.21 -91 Powered by Capital Market - Live
Ambuja Cements will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
The key equity indices ended near flat line today. Investors will keep track a crucial economic data including US GDP data, scheduled later this week. Further, market participants will closely monitor rupee movement, FII activity, ongoing IPO activity, and global cues. The Nifty settled above the 26,150 mark. Media, metal and FMCG shares advanced and IT, PSU Bank and Pharma stocks declined. As per provisional closing data, the barometer index, the S&P BSE Sensex declined 42.64 points or 0.05% to 85,524.84. The Nifty 50 index gained 4.75 points or 0.02% to 26,177.15. In the broader market, the S&P BSE Mid-Cap index surged 0.38% and the S&P BSE Small-Cap index rose 0.08%. The market breadth was positive. On the BSE, 2,293 shares rose and 1,889 shares fell. A total of 200 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, tumbled 3.07% to 9.38. IPO Update: Gujarat Kidney and Super Speciality received bids for 3,38,15,808 shares as against 1,32,26,880 shares on offer, according to stock exchange data at 15:30 IST on Tuesday (23 December 2025). The issue was subscribed 2.56 times. The issue opened for bidding on 22 December 2025 and it will close on 24 December 2025. The price band of the IPO is fixed between Rs 108 and 114 per share. New Listing: Shares of KSH International were currently trading at Rs 354.55 ended on the BSE, representing a discount of 7.67% as compared with the issue price of Rs 384. The stock debuted at Rs 370 on the BSE, exhibiting a discount of 3.65% over the issue price. The stock has hit a high of 370 and a low of 350.05. On the BSE, over 5.72 lakh shares of the company were traded in the counter. Economy: The combined Index of Eight Core Industries (ICI) increased by 1.8% (provisional) in November, 2025 as compared to the Index in November, 2024. The production of Cement, Steel, Fertilizer and Coal recorded positive growth in November, 2025. Coal production rose 2.1% in November 2025 compared with November 2024. Crude oil output declined 3.2% year-on-year, while natural gas production fell 2.5% during the same period. Petroleum refinery production also slipped 0.9% in November 2025 over a year ago. Steel production increased 6.1% year-on-year, cement output surged 14.5%, while electricity generation declined 2.2% in November 2025 compared with November 2024. Fertilizer production increased by 5.6% YoY in November 2025. Buzzing Index: The Nifty Media index climbed 0.80% to 1,413.60. The index jumped 1.46% for the four consecutive trading sessions. Nazara Technologies (up 5.25%), Network 18 Media & Investments (up 3.71%), Hathway Cable & Datacom (up 1.83%), Sun TV Network (up 1.8%), Prime Focus (up 1.59%) and D B Corp (up 0.81%) advanced. Stocks in Spotlight: Shares of Ambuja Cements and Orient Cement rose by 1.25% and 4.18%, respectively after Ambuja Cements announced a major consolidation plan. In a regulatory filing, Ambuja said its board has approved schemes to amalgamate ACC and Orient Cement into Ambuja Cements. The move will create a single pan-India cement platform. Under the proposed share swap, Ambuja will issue 328 equity shares of face value Rs 2 each for every 100 ACC shares of face value Rs 10 each. Orient Cement shareholders will receive 33 Ambuja shares of face value Rs 2 each for every 100 shares of Orient Cement with face value Re 1. Shakti Pumps India rose 2.72% after the company received a Letter of Empanelment/Award worth Rs 356.77 crore from the Maharashtra State Electricity Distribution Company (MSEDCL) for the supply of off-grid solar water pumping systems. RITES jumped 4.06% after it has won an international order worth $35.2 million from Ndalama Capital, South Africa for the supply and commissioning of in-service Cape gauge ALCO diesel-electric locomotives on a CIF basis. Larsen & Toubro (L&T) shed 0.28%. The company announced that its Hydrocarbon Onshore business vertical (L&T Onshore) has secured a major engineering, procurement, construction and commissioning (EPCC) order from Bharat Petroleum Corporation (BPCL). Puravankara zoomed 7.96% after it has acquired a 53.5-acre land parcel in Anekal Taluk, Bengaluru, with a potential gross development value of over Rs 4,800 crore. Antony Waste Handling Cell surged 5.94% after the company announced that its arm, Antony Lara Enviro Solutions, has secured a contract worth Rs 329.45 crore for the development of a mixed solid waste processing plant in Maharashtra. Global Markets: Most European markets advanced on Tuesday as investors awaited Spain's final GDP data, due later in the day. Provisional figures released last month showed year-on-year growth of 2.8%. Most Asian market ended higher, after AI trade lifted major Wall Street indexes overnight. Nvidia shares rose more than 1% after media reports said that the company was looking to start shipments of its H200 chips to China by mid-February. In Southeast Asia, Singapore will release its November inflation reading, with media reports stating that the city-state's inflation rate is expected to have climbed to its highest in 2025. Overnight in the U.S., the S&P 500 gained 0.64%, posting its third positive day in a row. The Dow Jones Industrial Average advanced 0.47%, and the Nasdaq Composite climbed 0.52%.Powered by Capital Market - Live
Orient Cement climbed 4.94% to Rs 171.95. Ambuja Cements gained 2.03% to Rs 550.95. However, ACC fell 0.78% to Rs 1762. In a regulatory filing, Ambuja said its board has approved schemes to amalgamate ACC and Orient Cement into Ambuja Cements. The move will create a single pan-India cement platform. The transaction is subject to regulatory and shareholder approvals and is expected to be completed within one year. Under the proposed share swap, Ambuja will issue 328 equity shares of face value Rs 2 each for every 100 ACC shares of face value Rs 10 each. Orient Cement shareholders will receive 33 Ambuja shares of face value Rs 2 each for every 100 shares of Orient Cement with face value Re 1. The company said the merger will improve operational efficiency by optimising manufacturing and logistics networks. It is also expected to simplify the corporate structure and enable better capital allocation. Ambuja estimates cost optimisation and margin improvement of at least Rs 100 per metric tonne from the merger. Karan Adani, non-executive director of Ambuja Cements, said the consolidation will strengthen scale, efficiency and long-term competitiveness of the cement business. Post-amalgamation, Ambuja aims to support its expansion plan to raise cement capacity from about 107 MTPA to 155 MTPA by FY28. The company added that the Ambuja and ACC brands will continue to operate independently in their respective markets. Ambuja Cements is the world's ninth-largest building materials solutions company and part of the Adani Group. It has a cement capacity of about 107 MTPA, supported by 24 integrated plants and 22 grinding units across India. The company is investing in decarbonisation initiatives, including 1 GW of renewable energy and 376 MW of waste heat recovery systems planned by FY28. Powered by Capital Market - Live
Ambuja Cements announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 December 2025.Powered by Capital Market - Live
Revenue from operations grew 18.99% YoY to Rs 9,431.53 crore, reflecting healthy demand and steady market traction. The company reported profit before exceptional items and tax of Rs 1,060.33 crore in Q2 FY26, compared to Rs 900.37 crore recorded in the same period a year ago. The firm reported exceptional items of Rs 222.80 crore during the quarter. Operational performance remained strong, with sales volume standing at 16.6 million tons in Q2 FY26, registering a growth of 20.29% on a YoY basis. In Q2 FY26, operating EBITDA rose 58.51% year-on-year to Rs 1,761 crore, while the EBITDA margin improved to 19.2%, compared to 14.7% in Q2 FY25. EBITDA per metric tonne (PMT) stood at Rs 1,060 in September 2025. The company's net worth stood at Rs 69,493 crore. It remains debt-free and continues to maintain its Crisil AAA (stable) and Crisil A1+ ratings. On the outlook front, Ambuja Cements said, 'Cement demand in Q2 FY26 was moderate and grew ~4% YoY. With GST reduction from 28% to 18%, improved economic sentiments, and higher investments from both the public and private sectors, the demand is expected to see an uptick, and we reaffirm our annual growth estimate of 7-8%.' The company noted that cement demand rose about 4% year-on-year in the September quarter and expects demand to gain further momentum in the coming months, supported by the GST rate reduction on cement from 28% to 18%, increased public and private investments, and improving consumer sentiment. Vinod Bahety, whole-time director & CEO of Ambuja Cements, said, 'This quarter has been noteworthy for the cement industry. Despite headwinds from prolonged monsoons, the sector will benefit from GST 2.0 reforms, CCTS, and withdrawal of coal cess. Our capacity expansion is well timed to capitalize on this positive momentum. We have upped our FY28 target capacity by 15 MTPA to 155 MTPA, coming at a much lower capex of $48/MT. Debottlenecking of logistics infrastructure will help improve utilization by 3%. We aim to deliver double-digit revenue growth, four-digit PMT EBITDA, and achieve a total cost of Rs 4,000 PMT by FY26, with a further 5% YoY reduction to Rs 3,650 PMT by FY28.' Ambuja Cements is a major cement-producing company in India. The principal activity of the company is to manufacture and market cement and clinker for both domestic and export markets.Powered by Capital Market - Live
Net profit of Ambuja Cements rose 268.22% to Rs 1765.71 crore in the quarter ended September 2025 as against Rs 479.53 crore during the previous quarter ended September 2024. Sales rose 24.98% to Rs 9129.73 crore in the quarter ended September 2025 as against Rs 7304.77 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales9129.737304.77 25 OPM %19.2915.22 - PBDT1945.481420.83 37 PBT1060.33900.37 18 NP1765.71479.53 268 Powered by Capital Market - Live
Ambuja Cements will hold a meeting of the Board of Directors of the Company on 3 November 2025.Powered by Capital Market - Live
Ambuja Cements announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 20 November 2025.Powered by Capital Market - Live
The Nifty September 2025 futures closed at 25,110, a premium of 104.5 points compared with the Nifty's closing at 25,005.50 in the cash market. In the cash market, the Nifty 50 index advanced 32.40 points or 0.13% to 25,005.50. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, declining 1.68% to 10.36. Ambuja Cements, Oracle Financial Services Software (OFSS) and Bombay Stock Exchange (BSE) were the top-traded individual stock futures contracts in the F&O segment of the NSE. The September 2025 F&O contracts will expire on 30 September 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.37%, vs industry avg of 11.67%
Over the last 5 years, market share decreased from 10.79% to 10.05%
Over the last 5 years, net income has grown at a yearly rate of 11.99%, vs industry avg of -0.39%